Te Ahumairangi Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85M | Buy |
83,227
+24,730
| +42% | +$1.14M | 0.69% | 56 |
|
|
2025
Q1 | $3.57M | Sell |
58,497
-14,647
| -20% | -$893K | 0.76% | 53 |
|
|
2024
Q4 | $4.14M | Sell |
73,144
-35,803
| -33% | -$2.03M | 0.86% | 47 |
|
|
2024
Q3 | $5.61M | Sell |
108,947
-37,110
| -25% | -$1.91M | 0.99% | 40 |
|
|
2024
Q2 | $6.07M | Sell |
146,057
-3,900
| -3% | -$162K | 1.17% | 31 |
|
|
2024
Q1 | $8.13M | Buy |
149,957
+4,250
| +3% | +$230K | 1.41% | 21 |
|
|
2023
Q4 | $7.48M | Sell |
145,707
-15,685
| -10% | -$805K | 1.42% | 21 |
|
|
2023
Q3 | $9.37M | Buy |
161,392
+1,470
| +0.9% | +$85.3K | 1.52% | 20 |
|
|
2023
Q2 | $10.2M | Buy |
159,922
+19,145
| +14% | +$1.22M | 1.39% | 21 |
|
|
2023
Q1 | $9.76M | Buy |
140,777
+15,865
| +13% | +$1.1M | 1.4% | 20 |
|
|
2022
Q4 | $8.99M | Buy |
124,912
+20,145
| +19% | +$1.45M | 1.41% | 22 |
|
|
2022
Q3 | $7.45M | Buy |
104,767
+2,190
| +2% | +$156K | 1.26% | 30 |
|
|
2022
Q2 | $7.9M | Sell |
102,577
-700
| -0.7% | -$53.9K | 1.19% | 34 |
|
|
2022
Q1 | $7.54M | Buy |
103,277
+600
| +0.6% | +$43.8K | 1.02% | 39 |
|
|
2021
Q4 | $6.4M | Sell |
102,677
-3,400
| -3% | -$212K | 0.83% | 51 |
|
|
2021
Q3 | $6.28M | Buy |
106,077
+7,000
| +7% | +$414K | 0.87% | 46 |
|
|
2021
Q2 | $6.62M | Buy |
99,077
+4,700
| +5% | +$314K | 0.87% | 47 |
|
|
2021
Q1 | $5.96M | Buy |
94,377
+12,500
| +15% | +$789K | 0.76% | 51 |
|
|
2020
Q4 | $5.08M | Buy |
81,877
+22,700
| +38% | +$1.41M | 0.71% | 56 |
|
|
2020
Q3 | $3.57M | Buy |
+59,177
| New | +$3.57M | 0.61% | 66 |
|